ScripThe pharmaceutical industry in Europe has criticized the Council of the EU’s adoption of a package of legislative reforms for medicines, claiming that the continent’s innovation-unfriendly environment
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Will Try Camurus’s FluidCrystal D
ScripIt has been a good week for Bayer’s oncology franchise, securing a third indication for its prostate cancer blockbuster Nubeqa and presenting positive data on its investigational menopause drug elinza
In VivoAs major pharmaceutical companies continue investing heavily in immunology –with Sanofi’s recent $9.1bn acquisition of Blueprint Medicines underscoring the sector’s strategic importance – San Franci